Scientific Program

src=http://www.doctaforum.net/congresos/gestor/ckfinder/userfiles/images/icons/icon-pdf.png

Download program in pdf

08:30 Welcome
Cristiana Sessa
ESMO Representative
  Manuel Llombart
Regional Minister for Health, Valencia, Spain
08:45 - 09:25 Keynote Lecture: Genomic Analysis
Michael J. Birrer · Massachusetts General Hospital, Boston (MA), USA
 
SESSION - 1 - PATHOGENESIS: FROM MORPHOLOGY TO MOLECULAR DIAGNOSIS
Chairs: Michael J. Birrer · Massachusetts General Hospital, Boston (MA), USA
Ignacio Romero · Fundación Instituto Valenciano de Oncología, Valencia, Spain
09:25 - 09:50 Molecular Pathogenesis
Robert  J. Kurman · The Johns Hopkins Hospital, Baltimore (MD), USA
09:50 - 10:15 Clinical Implications
Elise C. Kohn · National Cancer Institute, Bethesda (MD), USA
10:15 - 10:25 Discussion
 
SESSION - 2 - SURGERY IN OVARIAN CANCER
Chairs: Nicoletta Colombo · European Institute of Oncology, Milan, Italy
Sergi Martínez · Hospital Clínic Universitari, Barcelona, Spain
10:25 - 10:50 State of the Art of Surgery in Advanced Ovarian Cancer
Neville F. Hacker · Royal Hospital for Women, Randwick, Australia
10:50 - 11:30 Surgical Intervention in Relapsed Ovarian Cancer is Beneficial
10:50 - 11:05 In Favor
Philipp Harter · Kliniken Essen-Mitte, Essen, Germany
11:05 - 11:20 Contra
Maurie Markman · Cancer Treatment Centers of America, Eastern Regional Medical Center, Philadelphia (PA), USA
11:20 - 11:30 Discussion
11:30 - 12:00 Coffee Break
 
SESSION - 3 - SYSTEMIC THERAPY IN OVARIAN CANCER: 1st LINE
Chairs: Jan B. Vermorken · Antwerp University Hospital, Edegem, Belgium
Antonio Casado · Hospital Clínico San Carlos, Madrid, Spain
12:00 - 12:25 Do We Have a New Standard in Suboptimal Debulked Disease?
Michael A. Bookman · Arizona Cancer Center, Tucson (AZ), USA
12:25 - 12:50 Current Situation and New Developments in IP Chemotherapy
Joan L. Walker · University of Oklahoma Health Sciences Center, Oklahoma (OK), USA
12:50 - 13:15 Update on Non-Serous Ovarian Cancer Trials
Keiichi Fujiwara · Saitama Medical University, Saitama, Japan
13:15 - 13:30 Discussion
13:30 - 15:00 Lunch
 
SESSION - 4 - SYSTEMIC THERAPY IN OVARIAN CANCER: RECURRENT
Chairs: Sandro Pignata · National Cancer Institute, Pascale, Naples, Italy
José Mª Del Campo · Hospital General Vall d'Hebron, Barcelona, Spain
15:00 - 15:25 Update on Randomized Trials on Recurrent Disease
Antonio González · MD Anderson Cancer Center, Madrid, Spain
15:25 - 16:30 Bevacizumab Should Preferably Be Used in Recurrent Disease
15:25 - 15:45 In Favor
Eric Pujade-Lauraine · Hôpital Hôtel-Dieu, Paris, France
15:45 - 16:05 Contra
Bradley J. Monk · St Joseph's Hospital and Medical Center
, Phoenix (AZ), USA
16:05 - 16:30 Discussion
16:30 - 17:00 Coffee Break
 
SESSION - 5 - NEW DEVELOPMENTS
Chairs: Elizabeth Eisenhauer · Queen's University, Kingston (ON), Canada
Andrés Cervantes · Hospital Clínico Universitario, Valencia, Spain
17:00 - 17:25 Targeted Therapies and Clinical Trials
Janet Dancey · Queen's University, Kingston (ON), Canada
17:25 - 17:50 Patient Reported Outcome in Clinical Trials
Michael Friedlander · Prince of Wales Hospital, Randwick, Australia
17:50 - 18:15 New Outlook for the Future
Stanley B. Kaye · The Royal Marsden Hospital, London, United Kingdom
18:15 - 18:30 Remarks and Conclusions
Andrés Poveda · Fundación Instituto Valenciano de Oncología, Valencia, Spain

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información.

ACEPTAR